The American Diabetes Association Standards of Medical Care in Diabetes (2020) also recommend SMBG for patients on non-insulin therapies who require adjustment of diet, physical activity, or medications, and CGM for individuals with type 2 diabetes who have not achieved glycemic targets [5]. Here, INS is linked to type 2 diabetes mellitus.